Dr. Olaguoke K. Akinwande, MD

Dr. Akinwande practices at Midwest Institute for Non-Surgical Therapy in Saint Louis, Missouri.

Dr. Akinwande's NPI, 1235362252, was assigned on August 25, 2009. Dr. Akinwande holds Missouri license 2016010164.

Dr. Akinwande's primary practice is Midwest Institute for Non-Surgical Therapy, at 2 Clayton Court Dr, Saint Louis, MO 63131 in Saint Louis County. The practice phone is (314) 255-2204.

Dr. Akinwande's primary practice is Midwest Institute for Non-Surgical Therapy in Saint Louis, Missouri. The medical group on file is USA Radiology Management Solutions. Dmand AI also links Dr. Akinwande to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Akinwande practices, 2 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Akinwande's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Akinwande is licensed in Missouri.

CMS data shows 948 Medicare services from Dr. Akinwande across 17 procedure codes in 2024, for 185 Medicare patients. Medicare paid $703,958 for them. Every service was in an office.

CMS counts 185 Medicare patients who saw Dr. Akinwande in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Akinwande's median patient age at 69, with 52% women.

In 2024, Dr. Akinwande wrote 321 Medicare Part D claims for 126 patients. 72% of them were for generic drugs. CMS names the drug for 293 of them, across 3 drugs with 11 or more claims each, at $82,251 in total drug cost. In 2023, CMS named 336 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Akinwande for performance year 2024, reported individually. Dr. Akinwande accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Akinwande as offering telehealth. CMS counts 80 procedures of leg revascularization (restoring blood flow) by Dr. Akinwande, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 34 papers to Dr. Akinwande, published from 2013 to 2019. 2018 was the busiest year, with 7. The most frequent topics are Liver Neoplasms, Embolization, Therapeutic and Chemoembolization, Therapeutic. Dr. Akinwande has published most often in Anticancer Res. Dr. Akinwande's most frequent co-authors are Raja Ramaswamy, MD, Seung Kwon Kim, MD and Michael David Darcy, MD.

Dmand AI links Dr. Akinwande to 1 clinical trial. Conditions studied include Rectal Diseases and Colorectal Neoplasms.

CMS Open Payments shows 164 general payments to Dr. Akinwande from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 45% of the total. Philips Electronics North America Corporation paid the most, $10,275.